Product logins

Find logins to all Clarivate products below.


Orthopedic Extremity Devices | Europe (Supplemental) | 2018 | Market Analysis

The European orthopedic extremity device market will grow at a moderate pace through 2026, primarily as a result of favorable demographics, innovation in underpenetrated segments, an ongoing focus on surgeon training, and the uptake of premium-priced products. However, lingering economic uncertainty, cost constraints on hospitals, and the prevalence of alternative techniques will limit ASPs and revenue expansion over the forecast period.

This Medtech 360 Report provides high-level market metrics for orthopedic extremity devices in Europe, including country-level data for major countries and aggregate data for the rest of Europe, across a 10-year period.

Related Medtech Insights Reports

Report
Interventional Cardiology Devices – Market Insights – Europe
The European interventional cardiology device market is highly competitive and poised for moderate growth over the forecast period, driven by increasing PCI volumes for complex CAD cases and the…
Report
Electrophysiology Mapping and Ablation Devices – Market Insights – Europe
The European EP mapping and ablation device market will grow moderately through 2035, driven by the rising prevalence of cardiac arrhythmias, improved access to treatment, advancements in ablation…
Report
Aortic Repair Devices – Market Insights – Europe
The European aortic stent graft market is the primary driver of growth in the aortic repair device market and will drive revenue expansion over the forecast period, supported by ongoing innovation…
Report
Cardiac Rhythm Management Devices – Market Insights – Europe
The European CRM device market will continue to grow modestly over the forecast period because of rising ICM procedure volumes, the introduction of dual-chamber leadless pacemakers, and increased…
Report
Gastrointestinal Endoscopy Devices – Market Insights – Europe
The European GI endoscopy device market will be driven primarily by the high incidence of gastric cancer and CRC in the region. Market growth will be supported by nationwide CRC and GI cancer…